menu search

Camden national (cac) surges 6.2%: is this an indication of further gains?

Camden National (cac) was a big mover last session on higher-than-average trading volume. The latest tr...

March 3, 2022, 6:55 am

Camden national (cac) surges 6.2%: is this an indication of further gains?

Camden National (cac) was a big mover last session on higher-than-average trading volume. The latest tr...

March 3, 2022, 6:55 am

Credit acceptance (cacc) up 1.1% since last earnings report: can it continue?

Credit Acceptance (cacC) reported earnings 30 days ago. What's next for the stock?...

March 2, 2022, 1:47 pm

Credit acceptance (cacc) up 1.1% since last earnings report: can it continue?

Credit Acceptance (cacC) reported earnings 30 days ago. What's next for the stock?...

March 2, 2022, 1:47 pm

Credit acceptance (cacc) up 1.1% since last earnings report: can it continue?

Credit Acceptance (cacC) reported earnings 30 days ago. What's next for the stock?...

March 2, 2022, 1:47 pm

Ncr and stratacache partner on digital menu rollout

Enterprise technology provider NCR Corporation on Tuesday (March 1) announced a partnership with global digital signage and retail marketing platform ...

March 1, 2022, 2:36 pm

Ncr and stratacache partner on digital menu rollout

Enterprise technology provider NCR Corporation on Tuesday (March 1) announced a partnership with global digital signage and retail marketing platform ...

March 1, 2022, 2:36 pm

Ncr and stratacache partner on digital menu rollout

Enterprise technology provider NCR Corporation on Tuesday (March 1) announced a partnership with global digital signage and retail marketing platform ...

March 1, 2022, 2:36 pm

Glaxosmithkline gains european marketing approval for kidney disease drug daprodustat

GlaxoSmithKline PLC (LSE:GSK) hit a major milestone after its drug for treating chronic kidney disease gained marketing permission from the European M...

March 1, 2022, 5:20 am

Glaxosmithkline gains european marketing approval for kidney disease drug daprodustat

GlaxoSmithKline PLC (LSE:GSK) hit a major milestone after its drug for treating chronic kidney disease gained marketing permission from the European M...

March 1, 2022, 5:20 am

Glaxosmithkline gains european marketing approval for kidney disease drug daprodustat

GlaxoSmithKline PLC (LSE:GSK) hit a major milestone after its drug for treating chronic kidney disease gained marketing permission from the European M...

March 1, 2022, 5:20 am

cactus, inc.'s (whd) ceo scott bender on q4 2021 results - earnings call transcript

cactus, Inc.'s (WHD) CEO Scott Bender on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 3:12 pm

cactus, inc.'s (whd) ceo scott bender on q4 2021 results - earnings call transcript

cactus, Inc.'s (WHD) CEO Scott Bender on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 3:12 pm

cactus, inc.'s (whd) ceo scott bender on q4 2021 results - earnings call transcript

cactus, Inc.'s (WHD) CEO Scott Bender on Q4 2021 Results - Earnings Call Transcript...

February 28, 2022, 3:12 pm

cactus, inc. (whd) surpasses q4 earnings and revenue estimates

cactus, Inc. (WHD) delivered earnings and revenue surprises of 25% and 5.69%, respectively, for the qua...

February 28, 2022, 9:14 am

cactus, inc. (whd) surpasses q4 earnings and revenue estimates

cactus, Inc. (WHD) delivered earnings and revenue surprises of 25% and 5.69%, respectively, for the qua...

February 28, 2022, 9:14 am

cactus, inc. (whd) surpasses q4 earnings and revenue estimates

cactus, Inc. (WHD) delivered earnings and revenue surprises of 25% and 5.69%, respectively, for the qua...

February 28, 2022, 9:14 am


Search within

Pages Search Results: